Fate Therapeutics, Inc. trades on the Nasdaq stock exchange under the ticker symbol FATE, with its share price fluctuating continuously during active market hours. Recent financial market data places the equity trading at approximately 2.44 USD per share, moving within a 52-week trading range that spans from a low of roughly 0.93 USD up to a high of 3.23 USD. Because stock valuations change dynamically in response to quarterly earnings reports, clinical trial updates, and broader market conditions, investors seeking precise, up-to-the-minute quotes and trading volume metrics should consult live financial terminals or brokerage platforms.